Independent directory Public ClinicalTrials.gov records United States
Clear filters

The live registry is temporarily unavailable. These stored records may be incomplete or out of date. Check the official record for current status and contact information.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 9:08 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 913–936 of 2,910 matching trials from the local directory fallback.
Recruiting Not applicable Interventional Accepts healthy volunteers

Utilizing Pediatric Primary Care Connections to Advance Reproductive Health

NCT07064837
Conditions
Contraceptive Use
Interventions
Conecta Familia, Contraceptive need survey
Other
Lead sponsor
Johns Hopkins University
Other
Eligibility
18 Years and older · Female only
Enrollment
200 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2024 – 2028
U.S. locations
1
States / cities
Baltimore, Maryland
Recruiting Not applicable Interventional

CAPABLE Transplant

NCT06326905
Conditions
Depression, Disability Physical, End Stage Renal Disease, Quality of Life
Interventions
CAPABLE Transplant- Open Label Pilot, CAPABLE Transplant- Randomized Control Trial
Behavioral
Lead sponsor
Johns Hopkins University
Other
Eligibility
18 Years to 99 Years
Enrollment
43 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2027
U.S. locations
1
States / cities
Baltimore, Maryland
Recruiting Not applicable Interventional Accepts healthy volunteers

Motiva Implants® Post-Approval Study

NCT06938399
Conditions
Breast Implant
Interventions
Aesthetic Surgery, Silicone gel-filled breast implants - Motiva Implants®
Other · Device
Lead sponsor
Motiva USA LLC
Industry
Eligibility
22 Years and older · Female only
Enrollment
2,400 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2025 – 2037
U.S. locations
33
States / cities
Beverly Hills, California • Camp Pendleton, California • Los Gatos, California + 26 more
Conditions
Traumatic Brain Injury
Interventions
Active movement training with limited wearable ankle robot, Ankle/Wrist torque and motion measurement with limited wearable ankle/wrist robot, Gamed-based active movement training with wearable ankle robot, Motor relearning training with wearable ankle robot, Passive movement with limited wearable ankle robot, Passive stretching with wearable ankle robot
Device
Lead sponsor
University of Maryland, Baltimore
Other
Eligibility
30 Years to 85 Years
Enrollment
100 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2030
U.S. locations
1
States / cities
Baltimore, Maryland
Recruiting No phase listed Observational Accepts healthy volunteers

Deep Functional Phenotyping of the ALA Lung Health Cohort

NCT06177717
Conditions
Lung Diseases
Interventions
Not listed
Lead sponsor
Johns Hopkins University
Other
Eligibility
25 Years to 35 Years
Enrollment
1,000 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2024 – 2027
U.S. locations
12
States / cities
Birmingham, Alabama • Los Angeles, California • Denver, Colorado + 9 more
Conditions
Opioid Use Disorder
Interventions
Psilocybin
Drug
Lead sponsor
Johns Hopkins University
Other
Eligibility
21 Years to 70 Years
Enrollment
90 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2029
U.S. locations
1
States / cities
Baltimore, Maryland
Conditions
Castration Resistant Metastatic Prostate Cancer
Interventions
Enzalutamide, Testosterone cypionate, Testosterone enanthate
Drug
Lead sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Other
Eligibility
18 Years to 90 Years · Male only
Enrollment
150 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2020 – 2028
U.S. locations
6
States / cities
San Diego, California • Baltimore, Maryland • Boston, Massachusetts + 3 more
Conditions
Hypochondroplasia
Interventions
Not listed
Lead sponsor
QED Therapeutics, a BridgeBio company
Industry
Eligibility
30 Months to 16 Years
Enrollment
150 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2026
U.S. locations
8
States / cities
Oakland, California • Aurora, Colorado • Washington D.C., District of Columbia + 5 more
Recruiting Not applicable Interventional Accepts healthy volunteers

Multicenter HomeVENT: Home Values and Experiences Navigation Track

NCT06102330
Conditions
Communication, Pediatric ALL, Respiratory Insufficiency
Interventions
HomeVENT decision support tool
Other
Lead sponsor
Johns Hopkins University
Other
Eligibility
18 Years and older
Enrollment
600 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2024 – 2030
U.S. locations
4
States / cities
Tampa, Florida • New Orleans, Louisiana • Baltimore, Maryland + 1 more
Recruiting Not applicable Interventional Accepts healthy volunteers

Health-E You Efficacy Trial for Male Adolescents

NCT06525064
Conditions
Reproductive Health, Sexual Health, Sexually Transmitted Diseases
Interventions
Health-E You app
Other
Lead sponsor
Johns Hopkins University
Other
Eligibility
13 Years to 21 Years · Male only
Enrollment
2,752 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2026 – 2028
U.S. locations
8
States / cities
Oakland, California • Washington D.C., District of Columbia • Baltimore, Maryland + 5 more
Recruiting Not applicable Interventional Accepts healthy volunteers

text4FATHER R21: Social Media - Efficacy Trial

NCT06289101
Conditions
Fathers, Mobile Health, Nuclear Family
Interventions
text4FATHER
Behavioral
Lead sponsor
Johns Hopkins University
Other
Eligibility
18 Years and older
Enrollment
180 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2024 – 2027
U.S. locations
1
States / cities
Baltimore, Maryland
Recruiting Early Phase 1 Interventional Accepts healthy volunteers

Evaluation of the Electronic Cigarette Withdrawal Syndrome

NCT06066996
Conditions
E-cigarette Use, Withdrawal
Interventions
Placebo Nicotine Patch, Transdermal Nicotine Patch
Drug
Lead sponsor
Johns Hopkins University
Other
Eligibility
21 Years to 55 Years
Enrollment
150 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2023 – 2028
U.S. locations
1
States / cities
Baltimore, Maryland
Conditions
Extrapulmonary Neuroendocrine Carcinoma (EP-NEC), Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Carcinomas (NEC), Neuroendocrine Prostate Cancer (NEPC), Small Cell Lung Cancer (SCLC)
Interventions
Atezolizumab, Carboplatin + Etoposide, Irinotecan (drug), Lurbinectedin, Paclitaxel., Peluntamig (PT217), Topotecan
Drug
Lead sponsor
Phanes Therapeutics
Industry
Eligibility
18 Years and older
Enrollment
203 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2028
U.S. locations
15
States / cities
Duarte, California • Los Angeles, California • Denver, Colorado + 11 more
Conditions
Abdominal Wound Dehiscence, Anal Fistula, Hidradenitis Suppurativa, Lower Extremity Wound, Necrotizing Soft Tissue Infection, Pilonidal Sinus, Pressure Injury
Interventions
Myriad Matrix™ and Myriad Morcells™
Device
Lead sponsor
Aroa Biosurgery Limited
Industry
Eligibility
18 Years and older
Enrollment
800 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2022 – 2029
U.S. locations
15
States / cities
Phoenix, Arizona • Los Angeles, California • Fort Myers, Florida + 11 more
Conditions
Prostate Cancer (Adenocarcinoma)
Interventions
ADT, Abiraterone, Apalutamide, Darolutamide (BAY 1841788), Docetaxel, Enzalutamide
Drug
Lead sponsor
Canadian Cancer Trials Group
Network
Eligibility
18 Years and older · Male only
Enrollment
830 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2031
U.S. locations
374
States / cities
Anchorage, Alaska • Fairbanks, Alaska • Phoenix, Arizona + 272 more
Conditions
Diabetes, Diabetic Foot, Diabetic Foot Ulcer, Peripheral Neuropathy
Interventions
Orpyx Sensory Insole System
Device
Lead sponsor
Johns Hopkins University
Other
Eligibility
18 Years and older
Enrollment
400 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2029
U.S. locations
1
States / cities
Baltimore, Maryland
Conditions
Glaucoma
Interventions
Anterior chamber (AC) tube placement, Sulcus tube placement
Procedure
Lead sponsor
University of Pennsylvania
Other
Eligibility
18 Years and older
Enrollment
226 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2027
U.S. locations
7
States / cities
San Francisco, California • Walnut Creek, California • Miami, Florida + 4 more
Conditions
Ovarian Cancer
Interventions
Gleolan
Drug
Lead sponsor
NX Development Corp
Industry
Eligibility
18 Years and older · Female only
Enrollment
170 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2029
U.S. locations
11
States / cities
Phoenix, Arizona • Jacksonville, Florida • Annapolis, Maryland + 8 more
Conditions
Periprosthetic Joint Infections
Interventions
EP Granules with Tobramycin, empty voids
Device
Lead sponsor
Elute, Inc.
Industry
Eligibility
22 Years and older
Enrollment
204 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2023 – 2029
U.S. locations
16
States / cities
Los Angeles, California • Washington D.C., District of Columbia • Skokie, Illinois + 12 more
Conditions
Arrythmia, Cardiomyopathies
Interventions
Conventional Management, Intra-Op Prophylactic VT ablation
Other · Procedure
Lead sponsor
University of Rochester
Other
Eligibility
18 Years and older
Enrollment
100 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2022 – 2027
U.S. locations
19
States / cities
Phoenix, Arizona • Los Angeles, California • San Francisco, California + 15 more
Conditions
End Stage Liver Disease
Interventions
Not listed
Lead sponsor
University of California, San Francisco
Other
Eligibility
18 Years and older
Enrollment
5,000 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2011 – 2030
U.S. locations
12
States / cities
Little Rock, Arkansas • Loma Linda, California • San Francisco, California + 9 more
Recruiting Phase 2Phase 3 Interventional

Human Penile Allotransplantation

NCT02395497
Conditions
Amputation, Amputation, Traumatic, Amputation, Traumatic/Surgery, Congenital Anomaly, Male Genitalia, Penis/Injuries, Penis/Surgery, Penis/Transplantation, Urologic Surgical Procedures, Male, Wounds and Injuries
Interventions
Monoclonal Antibody (Humanized Anti-CD52), Penile Allotransplantation, Tacrolimus
Biological · Procedure · Drug
Lead sponsor
Johns Hopkins University
Other
Eligibility
18 Years to 69 Years · Male only
Enrollment
60 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2014 – 2039
U.S. locations
1
States / cities
Baltimore, Maryland
Recruiting Phase 1 Interventional Accepts healthy volunteers

Cabotegravir-Hormone PK/PD Interactions for HIV Prevention

NCT07672717
Conditions
HIV, Injectable, Prophylaxis
Interventions
Cabotegravir Injectable Suspension (CAB LA)
Drug
Lead sponsor
Johns Hopkins University
Other
Eligibility
19 Years and older
Enrollment
32 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2026 – 2031
U.S. locations
1
States / cities
Baltimore, Maryland
Conditions
HIV Infections
Interventions
Midazolam, Placebo, VH4770359
Drug
Lead sponsor
ViiV Healthcare
Industry
Eligibility
18 Years to 55 Years
Enrollment
214 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2026 – 2027
U.S. locations
1
States / cities
Baltimore, Maryland